Author

Tiziana Triulzi

Fondazione IRCCS Istituto Nazionale dei TumoriORCID 0000-0003-3050-8676Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Assay:protein sequence· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

Alessandro GoriiD· 1 shared Antonino BelfioreiD· 1 shared Arianna BonizziiD· 1 shared Carlo MorassoiD· 1 shared Claudia ChiodoniiD· 1 shared Claudio TripodoiD· 1 shared Daniele LecisiD· 1 shared Davide PerniciiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alessandro GoriORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 1, 2026

ENPP3 expressed by HER2-positive breast cancer cells is associated with good prognosis by restraining epithelial-to-mesenchymal phenotype

Roberta Bongiorno, Maria Teresa Majorini, Valeria Figa'…·Daniele Lecis

This study shows that ENPP3 expression in HER2-positive breast cancer cells is linked to better prognosis by inhibiting epithelial-to-mesenchymal transition.

DOI 10.64898/2026.08.31.747828

mousehuman

𝕏 PostBluesky

BiochemistrybioRxivPreprintSep 18, 2025

Membrane Sensing Peptides -Enhanced SiMoA Platform for the Detection of HER2 on Extracellular Vesicles in Metastatic Breast Cancer Patients

Arianna Bonizzi, Paola Gagni, Francesca Piccotti…·Carlo Morasso

This paper introduces an enhanced SiMoA platform using membrane sensing peptides to detect HER2 on extracellular vesicles in metastatic breast cancer patients, showing improved sensitivity and prognostic relevance.

DOI 10.1101/2025.09.18.676908

humanproteomics

𝕏 PostBluesky